Generic Anxiety Medication Maker Hit With Contamination Suit

Breckenridge Pharmaceutical Inc. knowingly sold millions of tablets of duloxetine, a generic form of anti-anxiety medication Cymbalta, though it was contaminated with a carcinogenic, a proposed class action alleges.

The company announced a voluntary recall at the end of April due to elevated levels of nitrosamines, organic substances that can be produced during industrial processing and can increase cancer risk after prolonged exposure.

Because the recall covers more than 570,000 bottles containing between 90 to and 1000 tablets, “the sheer size of the recall” shows systemic failures to screen and eliminate nitrosamines, the complaint filed Wednesday in the US District ...